1. Out With the Old and In With the New, Again?

2. Out With the Old, In With the New

3. Current Standard of Care

4. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients

5. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients

6. FUSION SOF + RBV ± pegIFN in Treatment-experienced Patients With G2,3 HCV

7. VALENCE SOF + RBV for 12 Weeks or 24 Weeks in G2 or G3 HCV Infection

8. QUEST 1 and 2 Q80K Variant Adversely Affects SVR12 of SMV-based Therapy

9. COSMOS SOF + SIM ± RBV for G1 HCV-infected Patients by Fibrosis Stage

10. 2014 AASLD HCV Treatment Guidelines

11. ION-1 On the Road to IFN-free Therapy for G1 HCV Infection

12. ION-3 8 Weeks or 12 Weeks of SOF/LDV for Treatment-naive G1 HCV Infection

13. ION-2 SOF/LDV in G1 HCV-infected Patients Failing PegIFN/RBV ± DAA

14. HALLMARK-DUAL Phase 3 Trial of the All-oral Regimen DCV + ASV for G1b HCV Infection

15. SAPPHIRE I ABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV for G1 HCV Infection

16. SAPPHIRE II ABT-450/r/Ombitasvir + Dasabuvir + RBV (3D) G1 HCV

17. TURQUOISE II ABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV in Cirrhosis

18. The Past And Future of HCV Therapy

19. Abbreviations

20. Abbreviations (cont)

21. Abbreviations (cont)

22. References

23. References (cont)

24. References (cont)

25. References (cont)